MedTrace Logo

A Randomized Multicentre Study for the Acute Relief of Episodic and Chronic Cluster Headache.

NCT01958125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2019-02-26

Study results available
· View outcomes & findings →

Summary

The study will look at a non-invasive treatment for people suffering with chronic and episodic headaches. Study subjects will be randomized to an active treatment or an in-active treatment for 2 weeks. After the 2 weeks all subjects will continue to treat with an active treatment for an additional 2 weeks.

Conditions

  • Cluster Headache

Interventions

DEVICE

gammaCore

Vagal stimulation

Sponsors & Collaborators

  • ElectroCore INC

    lead INDUSTRY

Principal Investigators

  • Peter J. Goadsbury, Prof. · Royal Free Hospital, Dept for Neurology and Clinical Neurosciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-10-31
Completion
2015-01-31

Countries

  • Denmark
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01958125 on ClinicalTrials.gov